Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Joost Daemen , Nicolas M Van Mieghem Added: 10 months ago
Dive into our coverage of ESC Congress 2025 for groundbreaking trial results and discussions with expert faculty.Watch ourView From the Thoraxcenterseries for practice-focused reviews of the most anticipated trials from interventional experts,Prof Nicolas Van MieghemandDr Joost Daemen. Watch our Wrap-Upseries led byDr Mirvat Alasnag summarising the key take-aways from each day of the congress.For… View more
Research Area(s) / Expertise: Job title: Professor, Obesity and Stress Hormone Research
Prof Liesbeth van Rossum, MD PhD, is internist-endocrinologist and professor in the field of obesity and stress hormone research at the Erasmus University Medical Center in Rotterdam, Netherlands. Sheis also co-founder of the Obesity Center CGG, an internationally recognised academic centre of obesity management.Prof Van Rossum holds various societal and board positions, amongst the European lead… View more
Jas Gill

Author

Job title: GP with Special Interest in Cardiology
Dr Jas Gill is an award-winning GP in North West London. She is a GP with Special Interest in Cardiology at The Hillingdon Hospital NHS Foundation Trust. Her previous appointments include Clinical Lead for Diabetes in a London Clinical Commissioning Group through which she has helped shape diabetes care across North West London. She has represented at the Diabetes All Party Parliamentary… View more
Tom Ford

Author

Research Area(s) / Expertise:

Angina

Job title: Senior Lecturer & Interventional Cardiologist
Dr Tom Ford is an interventional cardiologist with subspecialty interest in angina, radial access techniques, invasive coronary assessment, and complex PCI. Tom graduated with the University Medal from Dundee, Scotland in 2007 and completed basic physician training in Edinburgh before emigrating to Australia in 2010. He qualified as a cardiologist (FRACP) training in Sydney’s Prince of Wales… View more
Author(s): Barry Borlaug Added: 1 year ago
THT Conference 2025 - Outcomes assessing the effect of obesity severity on tirzepatide in patients with obesity-related heart failure with preserved ejection fraction (HFpEF) show that patients on tirzepatide with a greater reduction in BMI and baseline waist-to-height ratio had greater improvements in exercise capacity and KCCQ quality of life scores.Dr Barry Borlaug (Mayo Clinic and Foundation,… View more